Cyclic and individualized administration of gonadotropin-releasing hormone agonists plus progestogens: An alternative protocol for contraception
article
OA: closed
CC0
AI-generated summary
This study found that cyclic GnRH agonist and progestogen administration prevented ovulation in 92.7% of cycles, with one pregnancy occurring, and suggested it as an alternative contraceptive for contraindicated women.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Twenty-one women presenting with different diseases, with absolute or relative contraindications to hormonal contraception or the use of intrauterine devices, received 300-600 micrograms/day buserelin intranasally from the 1st to the 21st day, and 5 mg/day norethisterone acetate orally from the 16th to the 23rd day of the cycle for a total of 245 cycles. Serum luteinizing hormone (LH), follicle-stimulating hormone (FSH), estradiol and testosterone were determined on days 3-5 and 13-15 of the cycle, while progesterone determinations and ovarian sonography were performed during the second half of the cycle. According to progesterone values, 92.7% of the treatment cycles were anovulatory, while in one cycle pregnancy was detected (0.4%). Values of serum LH, FSH and estradiol were low, and in most of the cycles ovarian follicular development was limited to follicles < or = 11 mm. In 21 treatment cycles (9%), statistically significant increases in FSH (p < 0.0001) and LH (p < 0.02), as well as ovarian proliferation to preovulatory follicles or luteinized follicles, were found. It appears that in spite of the high cost of medication and monitoring of patients, this regimen could be useful as an alternative in cases where other forms of contraception are contraindicated or have failed.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (3)
- Administration of Nasal Nafarelin as Compared with Oral Danazol for Endometriosis 1988
- GnRH Analogues in the Treatment of Endometriosis 1989
- Prevention of follicular maturation in endometriosis by subcutaneous infusion of luteinizing hormone-releasing hormone agonist started in the luteal phase 1988
References (26)
- Administration of Nasal Nafarelin as Compared with Oral Danazol for Endometriosis via openalex
- GnRH Analogues in the Treatment of Endometriosis via openalex
- Prevention of follicular maturation in endometriosis by subcutaneous infusion of luteinizing hormone-releasing hormone agonist started in the luteal phase via openalex
- W1967550469 via openalex
- W1969172579 via openalex
- W1971381346 via openalex
- W1981099117 via openalex
- W1999061392 via openalex
- W2012521400 via openalex
- W2032561688 via openalex
- W2041906714 via openalex
- W2067101889 via openalex
- W2095255691 via openalex
- W2101860906 via openalex
- W2205489142 via openalex
- W2286708478 via openalex
- W2396963332 via openalex
- W2397558617 via openalex
- W2398295129 via openalex
- W2408619637 via openalex
- W2416854702 via openalex
- W2463889139 via openalex
- W140454929 via openalex
- W2885338269 via openalex
- W562460450 via openalex
- W1893486843 via openalex
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- unpaywall
- last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0
· commercial use OK